ORGO News and Press, Organogenesis Holdings Inc. From 08/09/23

2023-08-09 16:12:17 ET Organogenesis Holdings press release ( NASDAQ: ORGO ): Q2 GAAP EPS of $0.04 beats by $0.01 . Revenue of $117.3M (-3.4% Y/Y) beats by $2.2M . Adjusted net income of $6.1 million for the second quarter of 2023, compared to an adjusted n...

CANTON, Mass., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today re...

2023-07-20 11:31:58 ET Summary Organogenesis is a solid player in the surgical care product market. Over its long existence, it has developed an important slate of core competencies. Small-cap biotech is a risky area, none more so than Organogenesis. Despite its helter-ske...

2023-07-17 11:49:11 ET Interested in discovering the top penny stocks to invest in? You’re certainly not the only one. Capitalizing on the stock market’s opportunities is the key to this process. However, the precise method of execution varies based on each individual ...

2023-07-14 11:02:27 ET Want to know how to find the best penny stocks to buy now? Of course you do and you’re not alone. Taking advantage of opportunities in the stock market is the way to do that. How to exactly go about it depends on individual trading style and strategies. ...

CANTON, Mass., July 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...

Alan Fisher appointed Chair of the Board of Directors Tim Cunningham joins as Chief Financial Officer ADELAIDE, Australia and CAMBRIDGE, Mass., July 03, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biotech...

2023-06-15 17:26:47 ET Morgan Stanley initiated coverage of Organogenesis ( NASDAQ: ORGO ) with an equal weight rating, citing concerns about reimbursement for its wound care products in certain settings. The investment bank said that the upcoming release of the Centers for Medi...

2023-05-24 15:02:19 ET Shares of Organogenesis (NASDAQ: ORGO) were up 15.4% Wednesday afternoon after being up as much as 21.2% Wednesday morning. The healthcare company sells advanced wound care products for surgical and sports medicine applications. Integra LifeSciences ...

Organogenesis Holdings Inc. (NASDAQ: ORGO) is one of today's top gainers. The company's shares are currently up 17.59% on the day to $4.04. Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgica...